Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PM54 and Pembrolizumab in Advanced Malignancies
NCT07644039Phase 2Recruiting
- Sponsor
- PharmaMar
- Start
- May 2026
- Primary completion
- Apr 2029
- Countries
- 2
01
Overview
A Phase 2 trial of PM54 in malignancy, sponsored by PharmaMar. Started May 2026; status: recruiting.
02
Drugs
PM54
03
Conditions
malignancy
Beyond the preview
Go deeper on NCT07644039.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07644039.